Results 181 to 190 of about 22,001 (226)
Some of the next articles are maybe not open access.
Lupus anticoagulants in children
Current Opinion in Hematology, 2003Lupus anticoagulant and ACAs are made up of heterogeneous IgG and IgM antibodies that prolong in vitro clotting times and are associated with increased risks of venous and arterial thrombosis, recurrent fetal loss, and autoimmune thrombocytopenia and anemia.
Michael, Briones, Thomas, Abshire
openaire +2 more sources
Lupus Erythematosus and Lupus Anticoagulant
1990Systemic lupus erythematosus (SLE) occurs primarily in young women, and it often complicates pregnancy. It has been speculated that this autoimmune disorder is so much more common in women than in men (10:1) because of their sensitization to nuclear antigens to which they are exposed during menstruation (Dameshek, 1958; Grimes et al., 1985; Hulka, 1985)
Kurt Benirschke, Peter Kaufmann
openaire +1 more source
The Journal of the Arkansas Medical Society, 1990
Lupus anticoagulants have been recognized as significant causes of morbidity in patients for many years. They were originally regarded by physicians and researchers as a nuisance. However, the name is a misnomer that has resisted change over the years. The riddle of the anticoagulant effect in vitro and the apparent procoagulant effect in vivo remains ...
openaire +1 more source
Lupus anticoagulants have been recognized as significant causes of morbidity in patients for many years. They were originally regarded by physicians and researchers as a nuisance. However, the name is a misnomer that has resisted change over the years. The riddle of the anticoagulant effect in vitro and the apparent procoagulant effect in vivo remains ...
openaire +1 more source
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Nature Medicine, 2022Andreas Mackensen +2 more
exaly
Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus
Science, 2022Richard K Perez +2 more
exaly